Research News

Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some

Medscape - Alexandre Malek, MD, assistant professor of medicine at LSUHS, pointed to "a growing number of preclinical studies evaluating the role of vaccines as adjunct to immunotherapy to overcome cancer resistance by converting cold tumors to hot." That research includes a study of a seasonal influenza vaccine and another of adenoviral based-vaccines.

Read More about Data Hint COVID-19 Vax May Improve Immunotherapy Efficacy in Some (opens in new window/tab)
LSUHS LARC hosts meeting on the threat of Methamphetamine use in Northwest Louisiana

LSUHS Louisiana Addiction Research Center hosted a meeting on Wednesday, Nov. 9, to discuss methamphetamine as an emerging drug threat in our region. Local law enforcement and community leaders were invited to have an open conversation and share information on drug problems in the region and determine how to raise awareness.

Read More about LSUHS LARC hosts meeting on the threat of Methamphetamine use in Northwest Louisiana
man looking through microscope in laboratory

Dr. Chris Kevil’s laboratory at LSUHS has discovered that a clinically approved cyclodextrin-based drug called Sugammadex can act as a hydrogen sulfide donor that restores vasoactive hydrogen. This innovation has already gone through initial in vivo testing with promising results.

Read More about LSU Health Shreveport and CarboHyde collaborate to develop cyclodextrins for restoring sulfide in various disease conditions
LSUHS and LSUS use AI to treat Cavernous Malformations

“Medicine in general is considerably complex and neurosurgery is extremely complex, with cavernous malformations among the most difficult to manage,” said Dr. Caleb Stewart, neurosurgeon at LSUHS. LSUHS, LSUS, Ochsner Health, and collaborators in Australia are now leveraging big data science and artificial intelligence (AI) to solve this challenge and improve care for patients.

Read More about LSUHS and LSUS use AI to treat Cavernous Malformations (opens in new window/tab)
two scientists in lab

The Louisiana Board of Regents has supported full five-year approval for the Louisiana Addiction Research Center (LARC) and Center for Emerging Viral Threats (CEVT), with the CEVT continuing to be a designated Center of Research Excellence. The Board of Regents approval follows unanimous approval of both centers by the LSU Board of Supervisors earlier this year. Both centers were previously granted provisional approval and applied for full center approval earlier this year.

Read More about LSUHS Research Centers Receive Full Authorization from LSU Board of Supervisors and Louisiana Board of Regents
Center For Emerging Viral Threats  Reaches Milestone Of Sharing 15,000 Sars-Cov-2 Sequences To Global Database

The Center of Excellence for Emerging Viral Threats’ (CEVT) Viral Genomics and Surveillance Lab has surpassed uploading its’ 15,000th sequence to GISAID (Global Initiative on Sharing Influenza Data). The LSU Health Shreveport CEVT team has worked tirelessly since early in the COVID-19 pandemic to sequence and track variants of SAR-CoV-2, the virus that causes the COVID-19 disease.

Read More about Center For Emerging Viral Threats Reaches Milestone Of Sharing 15,000 Sars-Cov-2 Sequences To Global Database
Research captures unfolding cardiovascular toll from meth use

A massive new study spotlights the toll methamphetamine use may take on heart health, suggesting men, people with kidney disease and those with high blood pressure are especially at risk. While researchers don't fully understand how meth use increases the risk for heart problems, they do know it creates a lot of stress on the body, shared Dr. Chris Kevil, LSUHS Vice Chancellor for Research.

Read More about Research captures unfolding cardiovascular toll from meth use (opens in new window/tab)
lady at podium outside

The Center for Brain Health at LSUHS has received a $100,000 gift to create the Noel Foundation, Inc. Endowed Professorship Honoring Dr. Robert C. Leitz, III in Parkinson’s Disease Research. It will expand the study of age-related neurodegenerative diseases and fund neurological training equipment for students studying at LSUHS. 

Read More about Noel Foundation Gives $100,000 for Parkinson’s Disease Research to LSUHS Center for Brain Health